ORCID as entered in ROS

Select Publications
2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?', AIDS, 29, pp. 2323 - 2333, http://dx.doi.org/10.1097/QAD.0000000000000805
,2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', Plos One, 10, pp. e0139981, http://dx.doi.org/10.1371/journal.pone.0139981
,2015, 'Immunological biomarkers predict HIV-1 viral rebound after treatment interruption', Nature Communications, 6, pp. 8495, http://dx.doi.org/10.1038/ncomms9495
,2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, 47, pp. 564 - 569, http://dx.doi.org/10.1097/PAT.0000000000000316
,2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing', Molecular Therapy Nucleic Acids, 4, pp. e261, http://dx.doi.org/10.1038/mtna.2015.31
,2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, 373, pp. 795 - 807, http://dx.doi.org/10.1056/NEJMoa1506816
,2015, 'Detecting antigen-specific T cell responses: From bulk populations to single cells', International Journal of Molecular Sciences, 16, pp. 18878 - 18893, http://dx.doi.org/10.3390/ijms160818878
,2015, 'Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals', Philosophical Transactions of the Royal Society B Biological Sciences, 370, http://dx.doi.org/10.1098/rstb.2014.0241
,2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', Lancet Infectious Diseases, 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5
,2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission', Plos Pathogens, 11, pp. e1005000, http://dx.doi.org/10.1371/journal.ppat.1005000
,2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, 29, pp. 911 - 919, http://dx.doi.org/10.1097/QAD.0000000000000625
,2015, 'T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses', Immunity, 42, pp. 704 - 718, http://dx.doi.org/10.1016/j.immuni.2015.03.002
,2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, 60, pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976
,2015, 'Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy', Journal of Infectious Diseases, 211, pp. 529 - 538, http://dx.doi.org/10.1093/infdis/jiu486
,2015, 'MAIT cells are depleted early but retain functional cytokine expression in HIV infection', Immunology and Cell Biology, 93, pp. 177 - 188, http://dx.doi.org/10.1038/icb.2014.91
,2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', Lancet HIV, 2, pp. e42 - e51, http://dx.doi.org/10.1016/S2352-3018(14)00061-7
,2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, 211, pp. 405 - 415, http://dx.doi.org/10.1093/infdis/jiu461
,2015, 'Promoter targeting RNAs: Unexpected contributors to the control of HIV-1 transcription', Molecular Therapy Nucleic Acids, 4, pp. e222, http://dx.doi.org/10.1038/mtna.2014.67
,2015, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, 89, pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704
,2015, 'Controlling HIV-1: Non-coding RNA gene therapy approaches to a functional cure', Frontiers in Immunology, 6, pp. 474, http://dx.doi.org/10.3389/fimmu.2015.00474
,2015, 'HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation', Plos One, 10, pp. e0140978, http://dx.doi.org/10.1371/journal.pone.0140978
,2015, 'The role of PKC-θ in CD4+ T cells and HIV infection: To the nucleus and back again', Frontiers in Immunology, 6, pp. 391, http://dx.doi.org/10.3389/fimmu.2015.00391
,2015, 'Allogeneic bone marrow transplantation in two HIV-1 infected patients shows no detectable HIV-1 RNA or DNA, and a profound reduction in HIV-1 antibodies', Pathology, 47, pp. S55 - S55, http://dx.doi.org/10.1097/01.pat.0000461459.26902.eb
,2015, 'P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions', Sexually Transmitted Infections, 91, pp. A168.2 - A168, http://dx.doi.org/10.1136/sextrans-2015-052270.438
,2015, 'Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.', World Journal of Virology, 4, pp. 219 - 244, http://dx.doi.org/10.5501/wjv.v4.i3.219
,2015, 'Retrospective audit of the freeliteTM serum free light chain (SFLC) assay: testing patterns, concordance with serum and urine electrophoresis/immunofixation and correlation with the N latex FLC assay', Pathology, 47, pp. S94 - S94, http://dx.doi.org/10.1097/01.pat.0000461601.28805.d5
,2014, 'The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: Design and methods', BMC Public Health, 14, pp. 917, http://dx.doi.org/10.1186/1471-2458-14-917
,2014, 'MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY', INTERNAL MEDICINE JOURNAL, 44, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Early immune adaptation in HIV-1 revealed by population-level approaches', Retrovirology, 11, pp. 64, http://dx.doi.org/10.1186/s12977-014-0064-1
,2014, 'Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?', Clinical and Translational Immunology, 3, pp. e19, http://dx.doi.org/10.1038/cti.2014.12
,2014, 'Moving away from ritonavir, abacavir, tenofovir, and efavirenz (RATE) - Agents that concern prescribers and patients: A feasibility study and call for a trial', Plos One, 9, pp. e99530, http://dx.doi.org/10.1371/journal.pone.0099530
,2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', MICROBIOLOGY AUSTRALIA, 35, pp. 103 - 104, http://dx.doi.org/10.1071/MA14033
,2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', Plos One, 9, pp. e93333, http://dx.doi.org/10.1371/journal.pone.0093333
,2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, 15, pp. 65 - 76, http://dx.doi.org/10.1111/hiv.12080
,2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, 28, pp. 2480 - 2483, http://dx.doi.org/10.1097/QAD.0000000000000461
,2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', Lancet, 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X
,2014, 'Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome', Journal of Virology, 88, pp. 12793 - 12801, http://dx.doi.org/10.1128/JVI.02016-14
,2014, 'Global burden of transmitted HIV drug resistance and HIV-exposure categories: A systematic review and meta-analysis', AIDS, 28, pp. 2751 - 2762, http://dx.doi.org/10.1097/QAD.0000000000000494
,2014, 'HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy', Journal of Virology, 88, pp. 3516 - 3526, http://dx.doi.org/10.1128/JVI.03331-13
,2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control', Elife, 3, pp. e03821, http://dx.doi.org/10.7554/eLife.03821
,2014, 'HIV-specific antibody-dependent phagocytosis matures during HIV infection', Immunology and Cell Biology, 92, pp. 679 - 687, http://dx.doi.org/10.1038/icb.2014.42
,2014, 'Human antigen-specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses', European Journal of Immunology, 44, pp. 1644 - 1661, http://dx.doi.org/10.1002/eji.201344102
,2014, 'Impaired Nef function is associated with early control of HIV-1 viremia', Journal of Virology, 88, pp. 10200 - 10213, http://dx.doi.org/10.1128/JVI.01334-14
,2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy', Journal of Infection, 68, pp. 344 - 354, http://dx.doi.org/10.1016/j.jinf.2013.11.016
,2014, 'MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection', Current Opinion in HIV and AIDS, 9, pp. 464 - 471, http://dx.doi.org/10.1097/COH.0000000000000089
,2014, 'NKT cell depletion in humans during early HIV infection', Immunology and Cell Biology, 92, pp. 578 - 590, http://dx.doi.org/10.1038/icb.2014.25
,2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients', Immunology and Cell Biology, 92, pp. 384 - 388, http://dx.doi.org/10.1038/icb.2013.101
,2014, 'Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: An observational cohort study', Lancet HIV, 1, pp. e119 - e126, http://dx.doi.org/10.1016/S2352-3018(14)00002-2
,2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', Microbiology Australia, 10, pp. 1071
,2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting', AIDS Research and Human Retroviruses, 29, pp. 1621 - 1625, http://dx.doi.org/10.1089/aid.2013.0132
,